Description

3'-Methyl-1',4',6',7'-Tetrahydrospiro[[1,3]Dioxolane-2,5'-Indazole] is a high-purity, advanced pharmaceutical intermediate characterized by its unique spirocyclic indazole structure. This compound matters for its critical role as a sophisticated building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring complex molecular architectures. Pharmaceutical R&D teams and fine chemical manufacturers need this material to develop next-generation drug candidates with enhanced selectivity and efficacy.

Application

• Pharmaceutical Intermediate: A key building block for the synthesis of novel drug candidates targeting a range of therapeutic areas.
• Organic Synthesis Research: Used in academic and industrial research to explore new chemical spaces and develop novel synthetic methodologies involving spirocyclic systems.
• Agrochemical Development: Serves as a precursor in the research and development of new crop protection agents with complex mode-of-action.
• Material Science: Investigated for the development of specialty chemicals and advanced materials requiring specific molecular frameworks.

Basic Information

Product Name	3'-Methyl-1',4',6',7'-Tetrahydrospiro[[1,3]Dioxolane-2,5'-Indazole]
CAS No.	1204220-26-7
Molecular Formula	C11H14N2O2
Molecular Weight	206.24 g/mol
Synonyms	3'-Methyl-1',4',6',7'-tetrahydrospiro[1,3-dioxolane-2,5'-indazole]; 3'-Methyl-1',4',6',7'-tetrahydrospiro[1,3-dioxolane-2,5'-indazole] (CAS 1204220-26-7); Spiro[1,3-dioxolane-2,5'-4,5,6,7-tetrahydro-3'-methylindazole]; 3'-Methyl-4,5,6,7-tetrahydrospiro[indazole-5,2'-[1,3]dioxolane]; 1204220-26-7; 3-Methyl-1,4,6,7-tetrahydrospiro[[1,3]dioxolane-2,5-indazole]; 3'-Methyl-1',4',6',7'-tetrahydrospiro[1,3-dioxolane-2,5'-indazole]
EINECS	Contact for details

Quality Control

Our 3'-Methyl-1',4',6',7'-Tetrahydrospiro[[1,3]Dioxolane-2,5'-Indazole] is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D and production. Certificates of Analysis (COA) with detailed specifications are provided for every shipment, ensuring full traceability and compliance with customer requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep away from heat, sparks, and open flame. The container should be kept tightly sealed when not in use to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Residual Solvents (GC)	Meets ICH Q3C guidelines
Water Content (KF)	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.